These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy. See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366 [TBL] [Abstract][Full Text] [Related]
9. Splicing efficiency of minor introns in a mouse model of SMA predominantly depends on their branchpoint sequence and can involve the contribution of major spliceosome components. Jacquier V; Prévot M; Gostan T; Bordonné R; Benkhelifa-Ziyyat S; Barkats M; Soret J RNA; 2022 Mar; 28(3):303-319. PubMed ID: 34893560 [TBL] [Abstract][Full Text] [Related]
10. Developmental arrest of Drosophila survival motor neuron (Smn) mutants accounts for differences in expression of minor intron-containing genes. Garcia EL; Lu Z; Meers MP; Praveen K; Matera AG RNA; 2013 Nov; 19(11):1510-6. PubMed ID: 24006466 [TBL] [Abstract][Full Text] [Related]
11. What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective. Blatnik AJ; McGovern VL; Burghes AHM Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445199 [TBL] [Abstract][Full Text] [Related]
12. Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons. Osman EY; Van Alstyne M; Yen PF; Lotti F; Feng Z; Ling KK; Ko CP; Pellizzoni L; Lorson CL JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32516136 [TBL] [Abstract][Full Text] [Related]
13. Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape. Wood MJA; Talbot K; Bowerman M Hum Mol Genet; 2017 Oct; 26(R2):R151-R159. PubMed ID: 28977438 [TBL] [Abstract][Full Text] [Related]
14. Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins. Huo Q; Kayikci M; Odermatt P; Meyer K; Michels O; Saxena S; Ule J; Schümperli D RNA Biol; 2014; 11(11):1430-46. PubMed ID: 25692239 [TBL] [Abstract][Full Text] [Related]
15. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy. d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471 [TBL] [Abstract][Full Text] [Related]
17. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Burghes AH; Beattie CE Nat Rev Neurosci; 2009 Aug; 10(8):597-609. PubMed ID: 19584893 [TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Passini MA; Bu J; Richards AM; Kinnecom C; Sardi SP; Stanek LM; Hua Y; Rigo F; Matson J; Hung G; Kaye EM; Shihabuddin LS; Krainer AR; Bennett CF; Cheng SH Sci Transl Med; 2011 Mar; 3(72):72ra18. PubMed ID: 21368223 [TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy. Liu H; Shafey D; Moores JN; Kothary R J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194 [TBL] [Abstract][Full Text] [Related]
20. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]